A new chapter in the fight against breast cancer was marked today as medical experts, healthcare leaders, and medical technology innovators gathered convened in Hanoi for the workshop “Innovations in Breast Cancer Diagnosis and Treatment”, graciously remarked by leader representatives of the Hanoi Department of Health.
Jointly organized by the Vietnam Society of Radiology and Nuclear Medicine (VSRNM) and Mammocare Hanoi, the event welcomed over 80 onsite attendees and more than 600 online participants, including clinicians from across northern Vietnam, representatives from AHK Vietnam – the German Industry and Commerce in Vietnam, and specialists from Siemens Healthineers.
The workshop “Innovations in Breast Cancer Diagnosis and Treatment” was graciously remarked by leader representatives of the Hanoi Department of Health.
The workshop underscored urgent projections from GLOBOCAN 2022, which anticipate a 59.4% increase in cancer incidence and a 70.3% rise in cancer-related mortality in Vietnam by 2040. Breast cancer remains the most commonly diagnosed cancer among Vietnamese women and the leading cause of cancer mortality, largely due to late detection and limited diagnostic capacity1.
A standout session on 50° Wide-Angle Tomosynthesis system of Siemens Healthineers highlighted its ability to capture 1mm breast slices, better tissue separation for more lesions detection, which is of often missed by 2D mammography due to tisue overlapping2 — particularly valuable for women with dense breast tissue. This supports earlier, more accurate diagnoses and reduces unnecessary biopsies.
The keynote presentation by Dr. Trinh Hoang Ha, Senior Director, Head of External Affairs at Siemens Healthineers Vietnam.
In his keynote, Dr. Trinh Hoang Ha, Senior Director, Head of External Affairs at Siemens Healthineers Vietnam, shared: “We pioneer breakthroughs in healthcare — for everyone, everywhere, sustainably. Our solutions go beyond technology, including education, financing, and remote support tailored to local needs.”
This message was echoed in a later session by Ms. Ton Thi My Linh, Ultrasound Clinical Sales Manager, Siemens Healthineers ASEAN. Her presentation highlighted the latest advancements in breast ultrasound, including elastography, which improves image clarity and diagnostic confidence in differentiating benign and malignant tissue.
MRI also took the spotlight for its critical role in early detection and treatment planning, especially for high-risk patients. The integration of AI and deep learning further enhances MRI’s potential by identifying cancer markers at earlier stages, even in healthy populations.
The hands-on session offered practical training in tomosynthesis interpretation, vacuum-assisted biopsies, and mammography reading
In the afternoon, hands-on session offered practical training in tomosynthesis interpretation, vacuum-assisted biopsies, and mammography reading — promoting cross-specialty learning and skill development.
As breast cancer remains the most commonly diagnosed cancer among women in Vietnam, and the fourth leading cause of cancer-related mortality3, workshops like this not only serve to disseminate the latest clinical and technological updates, but also reflect a shared mission - to make precise, accessible, and patient-centered care the new standard.